epirubicin has been researched along with Myocarditis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
AitRaiss, M; Benhmidoun, MA; Derhem, N; Elalouani, C; Elguenzri, A; Elhattaoui, M; Elomrani, A; Errehmouni, A; Faouzi, R; Khouchani, M; Mahmal, L; Rida, H; Tahri, A; Tazi, I | 1 |
1 other study(ies) available for epirubicin and Myocarditis
Article | Year |
---|---|
[Short and medium term cardiotoxicity of anthracyclins: a prospective study].
Topics: Adult; Aged; Anthracyclines; Antibiotics, Antineoplastic; Breast Neoplasms; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Morocco; Myocardial Contraction; Myocarditis; Neoplasms; Prospective Studies; Risk Factors; Time Factors; Ultrasonography; Ventricular Dysfunction, Left | 2012 |